Mainstay Medical International

Equities

MSTY

IE00BJYS1G50

Advanced Medical Equipment & Technology

Real-time Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-10.55%	-42.65%

03-12	Mainstay Medical Holdings plc Announces Publication of Clinical Results Comparing Older Patients and Younger Patients	CI
02-26	Mainstay Medical Holdings plc announced that it has received ?115 million in funding from a group of investors	CI

Mainstay Medical International plc Announces Completion of Pre-Submission Meeting with FDA

June 26, 2019 at 10:25 am

Mainstay Medical International plc announced that on 25 June 2019 the Company completed a pre-submission meeting with the U.S. Food and Drug Administration regarding a Pre-Market Approval (PMA) application submission for ReActiv8.

Latest news about Mainstay Medical International

Mainstay Medical Holdings plc Announces Publication of Clinical Results Comparing Older Patients and Younger Patients	03-12	CI
Mainstay Medical Holdings plc announced that it has received ?115 million in funding from a group of investors	02-25	CI
Mainstay Medical Holdings plc announced that it expects to receive funding	02-22	CI
Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on Reactiv8® Restorative Neurostimulation Systemtm	02-12	CI
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States	29/08/23	CI
Mainstay Medical Holdings plc Announces Publication of Three-Year Clinical Trial Data from Post-Market Clinical Follow-Up Registry of Reactiv8 in the United Kingdom	20/07/23	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2022	27/03/23	CI
Mainstay Medical Holdings plc Announces the Publication of Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact	02/03/23	CI
Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study in Chronic Low Back Pain Patients	22/11/22	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2021	28/03/22	CI
Mainstay Medical Holdings plc Announces Publication of Two-Year Patient Outcomes Data from Reactiv8-B Clinical Trial Demonstrating Long-Term Efficacy of Reactiv8 Restorative Neurostimulation	06/01/22	CI
Mainstay Medical Holdings plc Announces Appointment of Jeffrey Dunn and Eric Major to Its Board of Directors	14/12/21	CI
Mainstay Medical Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2020	09/07/21	CI
Mainstay Medical Announces Limited Announces Commercial Launch of ReActiv8® in US	29/06/21	CI
Oxford Finance LLC Announces Closing of $50 Million Senior Secured Term Loan with Mainstay Medical Holdings plc	20/04/21	CI
Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia	08/03/21	CI
Mainstay Medical Holdings plc announced that it has received $108 million in funding from Ally Bridge Group, KCK Group, Sofinnova Partners SAS, Fountain Healthcare Partners, and another investor	15/02/21	CI
Mainstay Medical Holdings plc announced a financing transaction	08/02/21	CI
Mainstay Medical Holdings plc Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain	22/06/20	CI
Mainstay Medical International plc Reports Earnings Results for the Full Year Ended December 31, 2019	25/02/20	CI
Mainstay Medical Announces Completion of Day 100 Meeting with FDA Regarding Pre-Market Approval Application for ReActiv8	11/12/19	CI
Mainstay Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration for ReActiv8	06/12/19	CI
Mainstay Medical Announces Acceptance For Filing by US FDA Of Pre-Market Approval Application for ReActiv8	01/10/19	CI
Transcript : Mainstay Medical International plc, H1 2019 Earnings Call, Sep 20, 2019	20/09/19
Mainstay Medical International plc Reports Earnings Results for the Half Year Ended June 30, 2019	20/09/19	CI

Chart Mainstay Medical International

Duration

Period

More charts

Company Profile

Mainstay Medical International Ltd is an Ireland-based company. The Company is engaged in electromedical materials support services.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MAINSTAY MEDICAL INTERNATIONAL	-42.65%	29.84M
THERMO FISHER SCIENTIFIC	+10.03%	223B
DANAHER CORPORATION	+13.59%	195B
INTUITIVE SURGICAL, INC.	+20.01%	144B
BOSTON SCIENTIFIC CORPORATION	+30.83%	111B
SIEMENS HEALTHINEERS AG	+2.05%	65.01B
EDWARDS LIFESCIENCES CORPORATION	+15.38%	53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	50.45B
AGILENT TECHNOLOGIES, INC.	+8.37%	44.15B
GE HEALTHCARE TECHNOLOGIES INC.	+3.27%	36.45B

Other Advanced Medical Equipment & Technology